Report overview
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
This report aims to provide a comprehensive presentation of the global market for Platinum-based Anticancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum-based Anticancer Drugs. This report contains market size and forecasts of Platinum-based Anticancer Drugs in global, including the following market information:
Global Platinum-based Anticancer Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Platinum-based Anticancer Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Platinum-based Anticancer Drugs companies in 2022 (%)
The global Platinum-based Anticancer Drugs market was valued at US$ 1586.5 million in 2022 and is projected to reach US$ 1823.6 million by 2029, at a CAGR of 2.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.
Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.
Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.
We surveyed the Platinum-based Anticancer Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Platinum-based Anticancer Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Platinum-based Anticancer Drugs Market Segment Percentages, by Type, 2022 (%)
Cisplatin
Carboplatin
Oxaliplatin
Nedaplatin
Others
Global Platinum-based Anticancer Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Platinum-based Anticancer Drugs Market Segment Percentages, by Application, 2022 (%)
Testicular Cancer
Osteosarcoma
Breast Cancer
Esophageal Cancer
NSCLC
Other
Global Platinum-based Anticancer Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Platinum-based Anticancer Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Platinum-based Anticancer Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Platinum-based Anticancer Drugs revenues share in global market, 2022 (%)
Key companies Platinum-based Anticancer Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Platinum-based Anticancer Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira(Pfizer)
Mylan
Taj Pharmaceuticals
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Luoxin
Lingnan Pharmacy
Hansoh Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Platinum-based Anticancer Drugs, market overview.
Chapter 2: Global Platinum-based Anticancer Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Platinum-based Anticancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Platinum-based Anticancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Platinum-based Anticancer Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
